Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $1.28M invested in Processa Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
51% less capital invested
Capital invested by funds: $2.58M → $1.28M (-$1.31M)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$53.8K | |
| 2 | +$23.4K | |
| 3 | +$4.27K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.01K |
| 5 |
Renaissance Technologies
New York
|
+$2.72K |
Top Sellers
| 1 | -$111K | |
| 2 | -$28K | |
| 3 | -$5K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20 |